Low-dose antimony exposure promotes prostate cancer proliferation by inhibiting ferroptosis via activation of the Nrf2-SLC7A11-GPX4 pathway
Jianxi Shi, MA Chun-lei, Zhiwen Zheng, Tianxiao Zhang, Zhaopeng Li, Xiaoyu Sun, Zhen He, Zhihong Zhang, Changwen Zhang, Changwen Zhang
Topics & Concepts
AntimonyCarcinogenChemistryCancer researchCancerProgrammed cell deathToxicityIn vivoPharmacologyInternal medicineMedicineApoptosisBiologyBiochemistryGeneticsOrganic chemistryInorganic chemistryFerroptosis and cancer prognosisMicroRNA in disease regulationCancer, Lipids, and Metabolism